Novartis: all 3,900 studies
Page 26 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Association Between Patients' Perceptions of Success in Post-op Pain Management and Overall Experience With CareWithdrawnNCT02389907
- Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011CompletedNCT02388620Phase 1
- CINC424A2X01B Rollover ProtocolActive, not recruitingNCT02386800Phase 4
- A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsActive, not recruitingNCT02381886Phase 1
- PCA062 in pCAD-positive Tumors.CompletedNCT02375958Phase 1
- A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic FunctionCompletedNCT02372084Phase 1
- Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With MyelofibrosisCompletedNCT02370706Phase 1
- Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With LiposarcomaCompletedNCT02343172Phase 1
- PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking FingolimodCompletedNCT02335892
- First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy VolunteersCompletedNCT02334449Phase 1
- A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast CancerCompletedNCT02333370Phase 1
- The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THAWithdrawnNCT02333344Phase 4
- Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT02299505Phase 1
- Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.CompletedNCT02292550Phase 1
- Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaWithdrawnNCT02258009Phase 4
- Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL PatientsCompletedNCT02253277Phase 1
- A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374CompletedNCT02245828Phase 1
- Study of Afuresertib Combined With Paclitaxel in Gastric CancerCompletedNCT02240212Phase 1
- A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)TerminatedNCT02235740Phase 1
- Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKiaCompletedNCT02232503
- Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid LeukemiaTerminatedNCT02221505Phase 1
- Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyTerminatedNCT02205398Phase 1
- Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple MyelomaNo longer availableNCT02204553
- Phase 1 of EC1169 In Patients With Recurrent MCRPCCompletedNCT02202447Phase 1
- Observation of Treatment Patterns With Lucentis in Approved IndicationsCompletedNCT02194803
- Study of CLR457 Administered Orally in Adult Patients With Advanced Solid MalignanciesTerminatedNCT02189174Phase 1
- 99mTc-rhAnnexin V-128: a First In Man Study in Healthy VolunteersCompletedNCT02182609Phase 1
- Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma PatientsTerminatedNCT02177682Phase 1
- Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic MalignanciesCompletedNCT02160951Phase 1
- Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.CompletedNCT02154776Phase 1
- Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple MyelomaCompletedNCT02144038Phase 1
- Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wtCompletedNCT02143635Phase 1
- Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma PatientsWithdrawnNCT02143622Phase 1/2
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL PatientsTerminatedNCT02137889Phase 1
- Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled AsthmaWithdrawnNCT02127697Phase 3
- Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPDCompletedNCT02123199
- Canadian Treat and Extend Analysis Trial With RanibizumabCompletedNCT02103738
- Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 DaysWithdrawnNCT02099149
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis PatientsCompletedNCT02089087Phase 1
- Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast CancerCompletedNCT02088684Phase 1
- A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLCompletedNCT02081378Phase 1
- A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)CompletedNCT02078609Phase 1
- Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsCompletedNCT02077933Phase 1
- Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult SubjectsCompletedNCT02073812Phase 1
- Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent ThalassemiaWithdrawnNCT02069886Phase 4
- Urine Sample Collection From FOP PatientsCompletedNCT02066324
- A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT02058381Phase 1
- Mobile Clinic - a Cross-sectional Epidemiological SurveyCompletedNCT02055612
- A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453CompletedNCT02052687Phase 1
- A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck CancerCompletedNCT02051751Phase 1
- A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)TerminatedNCT02049281Phase 1
- Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.CompletedNCT02048787Phase 1
- To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With HypertensionTerminatedNCT02047656Phase 1
- Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast CancerCompletedNCT02023359
- The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal InsufficiencyCompletedNCT02020434Phase 1
- Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)CompletedNCT02014636Phase 1
- A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology ClinicsTerminatedNCT02005133
- Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid TumorsCompletedNCT01999738Phase 1
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With AcromegalyApproved for marketingNCT01995734
- Study to Evaluate the Impact of the "PROactive Telecoaching Program" on Physical Activity in Patients With COPD.WithdrawnNCT01992081Phase 4
- Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With HypercholesterolemiaCompletedNCT01979601Phase 1
- Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid TumorsCompletedNCT01968915Phase 1
- Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT01964235Phase 2
- Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)WithdrawnNCT01953536Phase 2
- Effect of Hepatic Impairment on LDK378 PharmacokineticsCompletedNCT01950481Phase 1
- Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High DosesWithdrawnNCT01948817Phase 2
- Expanded Treatment Protocol With LDK378 in ALK(+) NSCLCNo longer availableNCT01947608
- Safety and Efficacy of Fingolimod in MS Patients in ChinaWithdrawnNCT01941004Phase 3
- Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma MultiformeCompletedNCT01934361Phase 1
- Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in ChinaCompletedNCT01933646
- GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT01933516Phase 1
- Phase 1b Trial of BGJ398/BYL719 in Solid TumorsCompletedNCT01928459Phase 1
- Aliskiren Study of Safety and Efficacy in Senior HypertensivesWithdrawnNCT01922141Phase 4
- A Phase I Study of LJM716 in Japanese Patients With Advanced Solid TumorsCompletedNCT01911936Phase 1
- Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) PatientsTerminatedNCT01911325Phase 1
- A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal FunctionCompletedNCT01904214Phase 1
- Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® BirchCompletedNCT01902992Phase 3
- Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.WithdrawnNCT01900782Phase 3
- A Phase I Study of LEE011 in Asian PatientsCompletedNCT01898845Phase 1
- Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult SubjectsCompletedNCT01897779Phase 1
- PK of Serelaxin in Severe Renal Impairment and ESRDCompletedNCT01875523Phase 1
- Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerActive, not recruitingNCT01872260Phase 1/2
- Study of Muscle Effects of BYM338 in Mechanically Ventilated PatientsWithdrawnNCT01868685Phase 2
- Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With HypertensionWithdrawnNCT01865188Phase 3
- Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II DiabetesTerminatedNCT01862263Phase 4
- Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an EvaluationCompletedNCT01860105Phase 1
- A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPDWithdrawnNCT01860066Phase 3
- Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With StatinsCompletedNCT01859455Phase 1
- Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast CancerCompletedNCT01857193Phase 1
- Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell LymphomaCompletedNCT01854606Phase 1
- An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal DysfunctionCompletedNCT01846468Phase 1
- A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test FixtureWithdrawnNCT01845623Phase 2
- Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.WithdrawnNCT01837927Phase 3
- A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPDWithdrawnNCT01834885Phase 3
- A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological MalignanciesCompletedNCT01830010Phase 1
- Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in PsoriasisCompletedNCT01828086Phase 1
- Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected PatientsCompletedNCT01825980Phase 1/2
- Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With DiabetesWithdrawnNCT01824264Phase 2
- Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)CompletedNCT01822613Phase 1
- Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung CancerTerminatedNCT01820325Phase 1